Online inquiry

IVTScrip™ mRNA-Human ASNS, (Cap 1, N1-Methylpseudo-UTP, 30 nt-poly(A))   (CAT#: GTTS-WK27520MR)

This product GTTS-WK27520MR is a type of mRNA having 30 nt poly(A) tail and modified with Cap 1 & N1-Methylpseudo-UTP. It ecodes the ASNS protein. This product can be used in Mitotic arrest phase fetal germ cell-related researches.
Specifications
Product type mRNA
Modified bases N1-Methylpseudo-UTP
5' Cap Cap 1
Species Human
RefSeq NM_001178075.2
Applications Gene therapy research
Format Powder
Quantity 100 µg
Purification Chromatography
Target Gene
Gene ID 440
UniProt ID P08243
Download
Download resources about mRNA therapeutics development to boost your research.
CUSTOMER REVIEWS and Q&As

There are currently no Customer reviews or questions for IVTScrip™ mRNA-Human ASNS, (Cap 1, N1-Methylpseudo-UTP, 30 nt-poly(A)) (GTTS-WK27520MR). Click the button above to contact us or submit your feedback about this product.
See other products
CAT Product Name Product Type CDs
GTTS-WK22194MR IVTScrip™ mRNA-Human ATP5A1, (Cap 0, N1-Methylpseudo-UTP, 120 nt-poly(A)) mRNA ATP5A1
GTTS-WK20258MR IVTScrip™ mRNA-Human AMPD2, (Cap 1, N1-Methylpseudo-UTP, 30 nt-poly(A)) mRNA AMPD2
GTTS-WK9590MR IVTScrip™ mRNA-Human AGAP6, (Cap 0, N1-Methylpseudo-UTP, 30 nt-poly(A)) mRNA AGAP6
GTTS-WK27376MR IVTScrip™ mRNA-Human ARG1, (Cap 1, N1-Methylpseudo-UTP, 30 nt-poly(A)) mRNA ARG1
GTTS-WK3001MR IVTScrip™ mRNA-Human Intestinal Alkaline Phosphatase, (Cap 0, 5-Methyl-CTP, 30 nt-poly(A)) mRNA Intestinal Alkaline Phosphatase
GTTS-WK2044MR IVTScrip™ mRNA-Human AID, (Cap 0, Pseudo-UTP, 30 nt-poly(A)) mRNA AID
GTTS-WK19292MR IVTScrip™ mRNA-Human Aldehyde Dehydrogenase 1-A1, (Cap 1, 5-Methyl-CTP, 120 nt-poly(A)) mRNA Aldehyde Dehydrogenase 1-A1
GTTS-WK7414MR IVTScrip™ mRNA-Human ADARB2, (Cap 0, Pseudo-UTP, 120 nt-poly(A)) mRNA ADARB2
All products and services are For Research Use Only and CANNOT be used in the treatment or diagnosis of disease.
webinar

EABR Nanoparticles as a Platform Technology for Hybrid mRNA Vaccine Development

November 20th, 2024, 2 PM–3 PM EST

REGISTER NOW